143 related articles for article (PubMed ID: 14557175)
1. Prognostic value of the disodium phosphate 32P uptake test in uveal melanoma: a long-term study.
Overkleeft EN; Zuidervaart W; Hurks HM; Eilers PH; de Wolff-Rouendaal D; Jager MJ
Arch Ophthalmol; 2003 Oct; 121(10):1398-403. PubMed ID: 14557175
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
4. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
[TBL] [Abstract][Full Text] [Related]
5. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma.
Seregard S; Oskarsson M; Spångberg B
Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1451-8. PubMed ID: 8641848
[TBL] [Abstract][Full Text] [Related]
6. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
Coupland SE; Campbell I; Damato B
Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
8. Very long-term prognosis of patients with malignant uveal melanoma.
Kujala E; Mäkitie T; Kivelä T
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4651-9. PubMed ID: 14578381
[TBL] [Abstract][Full Text] [Related]
9. Radioactive phosphorus uptake test. An in vitro analysis of choroidal melanoma and ocular tissues.
Packer S; Shields JA; Christman DR; Wolf AP; Atkins HL
Invest Ophthalmol Vis Sci; 1980 Apr; 19(4):386-92. PubMed ID: 7358489
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy.
Augsburger JJ; Corrêa ZM; Freire J; Brady LW
Ophthalmology; 1998 Sep; 105(9):1670-8. PubMed ID: 9754176
[TBL] [Abstract][Full Text] [Related]
11. The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma.
Bagger M; Andersen MT; Andersen KK; Heegaard S; Andersen MK; Kiilgaard JF
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):438-44. PubMed ID: 25537201
[TBL] [Abstract][Full Text] [Related]
12. Uveal melanoma in the first 4 decades of life.
Sagus M; Bedikian AY
South Med J; 2015 Mar; 108(3):158-63. PubMed ID: 25772049
[TBL] [Abstract][Full Text] [Related]
13. Reduced melanoma-related mortality in uveal melanoma by preenucleation radiotherapy.
Kilic E; Stijnen T; de Jong PT; Mooy CM; Eijkenboom WM; Ringens PJ; Luyten GP
Arch Ophthalmol; 2005 Oct; 123(10):1363-7. PubMed ID: 16219727
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of 32P uptake in posterior uveal melanomas.
McLean IW; Shields JA
Ophthalmology; 1980 Jun; 87(6):543-8. PubMed ID: 7413143
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic study of malignant melanoma of the uvea treated by enucleation].
Bacin F; Kantelip B; Albuisson E; Bonhomme R
J Fr Ophtalmol; 1988; 11(10):639-49. PubMed ID: 3072363
[TBL] [Abstract][Full Text] [Related]
16. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma.
Mäkitie T; Carpén O; Vaheri A; Kivelä T
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2442-9. PubMed ID: 11581181
[TBL] [Abstract][Full Text] [Related]
17. [Intratumoral blood pools and prognosis of malignant uveal melanoma treated with enucleation].
Kantelip B; Albuisson E; Bacin F; Bonhomme R
Ophtalmologie; 1989; 3(1):49-52. PubMed ID: 2641072
[TBL] [Abstract][Full Text] [Related]
18. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
Frenkel S; Hendler K; Pe'er J
Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
[TBL] [Abstract][Full Text] [Related]
19. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
[TBL] [Abstract][Full Text] [Related]
20. [The follow up of prognostic important factors and analysis of five years survival rate in patients with uveal melanoma at the Department of Ophthalmology, 3rd Medical Faculty Charles University in Prague and the Faculty Hospital Královské Vinohrady in Prague].
Redinová MV; Sach J; Baráková D; Kuchynka P; Vránová J
Cesk Slov Oftalmol; 2009 Jan; 65(1):29-35. PubMed ID: 19366035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
